Pediatric Ketamine Study for Pain Management

PHASE4TerminatedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 1, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

October 14, 2017

Conditions
Pain
Interventions
DRUG

Ketamine

intranasal sub-dissociative dose ketamine for the treatment of moderate to severe pain in pediatric patients in the emergency department.

DRUG

Fentanyl

intranasal fentanyl for the treatment of moderate to severe pain in pediatric patients in the emergency department.

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Maimonides Medical Center

OTHER

lead

Antonios Likourezos

OTHER